Pacific Biosciences
PACB
1,33 €
Share price
-6.10%
Change (1 day)
-29.67%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €0.66 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are €0.66 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €0.72 B | -23.34% |
| 2023-12-31 | €0.94 B | -15.82% |
| 2022-12-31 | €1.12 B | 4.55% |
| 2021-12-31 | €1.07 B | 1582.6% |
| 2020-12-31 | €63.81 M | -23.19% |
| 2019-12-31 | €83.07 M | 69.07% |
| 2018-12-31 | €49.13 M | 1.69% |
| 2017-12-31 | €48.32 M | -4.49% |
| 2016-12-31 | €50.59 M | -3.91% |
| 2015-12-31 | €52.64 M | -7.79% |
| 2014-12-31 | €57.09 M | 17.68% |
| 2013-12-31 | €48.51 M | 216.14% |
| 2012-12-31 | €15.34 M | -25.78% |
| 2011-12-31 | €20.67 M | 6.27% |
| 2010-12-31 | €19.45 M | -89.98% |
| 2009-12-31 | €0.19 B | 31.47% |
| 2008-12-31 | €0.14 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | €3.30 B | 395.87% | 🇺🇸 USA |
 NanoString Technologies NSTG | €0.28 B | -57.71% | 🇺🇸 USA |
 General Electric GE | €90.58 B | 13,506.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | €42.89 B | 6,342.95% | 🇺🇸 USA |
 PerkinElmer
PKI | €5.71 B | 758.65% | 🇺🇸 USA |